Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted
The super T2-FLAIR mismatch sign was primarily observed in astrocytoma but also appeared in non-contrast-enhancing oligodendroglioma. It served as a prognostic biomarker for astrocytoma but not for oligodendroglioma.
Authors
- Vishwa Jeet Amatya
- Akira Taguchi (ORCID: https://orcid.org/0000-0003-2620-1487)
- Iori Ozono (ORCID: https://orcid.org/0000-0001-8987-4430)
- Ushio Yonezawa (ORCID: https://orcid.org/0000-0003-0448-4017)
- Nobutaka Horie (ORCID: https://orcid.org/0000-0002-0388-5188)
- Fumiyuki Yamasaki (ORCID: https://orcid.org/0000-0003-0164-6295)
- Novita Ikbar Khairunnisa (ORCID: https://orcid.org/0000-0001-5394-9867)
- Shumpei Onishi (ORCID: https://orcid.org/0000-0002-4156-6540)
- Yukio Takeshima
Institutions
- Hiroshima University (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1093/jjco/hyaf168
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00